TRUSTED CONTRACT RESEARCH ORGANIZATION
SPECIALIZING IN SMALL MOLECULE CHROMATOGRAPHY & PURIFICATION
At Averica, we understand drug development is challenging. For the last 15 years, we have been supporting the pharmaceutical industry and helping to advance programs all the way from early discovery to commercial testing. In particular, we specialize in method development, separations, and impurity isolation and identification.
TRUSTED CONTRACT RESEARCH ORGANIZATION
SPECIALIZING IN SMALL MOLECULE CHROMATOGRAPHY & PURIFICATION
At Averica, we understand drug development is challenging. For the last 15 years, we have been supporting the pharmaceutical industry and helping to advance programs all the way from early discovery to commercial testing. In particular, we specialize in method development, separations, and impurity isolation and identification.
Chiral preparative chromatography can support purification of a variety of difficult to purify substances (natural products, impurities and degradants, external contaminants).
Increasing attention on impurities in product development (degradants, solvents, external contaminants, genotoxic impurities, organic or inorganic) places an unprecedented burden on sponsors.
Developing analytical methods that are robust, transferable, reproducible, and designed to generate quality results is the ultimate goal. Averica’s method development services ensure that your team makes the best decisions and hits drug development milestones.
Averica helps late state lead development teams understand the physiochemical properties of their lead compound. Obtain detailed quantitative results from physical properties assessment using a range of chromatography technologies.
With the acquisition of Averica by Neopharm Labs in 2017, we now offer full GMP analytical development, testing and program support across the entire timeline of product development.
Averica are very skilled at what they do. They are very customer-oriented and very delivery-oriented.
Lisa Schaffter
Sr. Principal Research Scientist
You have a terrific business and have become my preferred provider of analytical development services. I will have lots more studies for you in the future.
Scott Hecker
Vice President, Chemistry
Averica has been and will continue to be a valuable resource for impurity isolation and identification projects. While many companies offer this service, it is a core strength at Averica, along with chiral method development.
Steve Wald
Vice President, Chemistry and Pharmaceutical Sciences
Beautiful chromatograms. I am continually impressed with the quality of your work.
Scott Collibee
Director, Medicinal Chemistry